All projects that had been approved before the Trump administration restrictions ‘will be reinstated without further review’
MONDAY, April 19, 2021 (HealthDay News) — Trump-era restrictions on the use of fetal tissue for medical research have been lifted by the Biden administration.
The reversal of the restrictions essentially restores the guidelines in place during the Obama administration, The New York Times reported.
That means that scientists will again be permitted to use tissue from elective abortions in research to learn more about and try to find treatments for a number of diseases, including diabetes, cancer, AIDS, and COVID-19.
Scientists will be allowed to buy fetal tissue from sources approved before the ban, and all projects that had been approved before the Trump administration restrictions “will be reinstated without further review,” according to an email sent to scientists by the National Institutes of Health, The Times reported.
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy 
A-Fib Occurs Frequently in Patients With Multiple Myeloma Undergoing Stem Cell Transplant 
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum 
High-Dose Omega-3 Linked to A-Fib Risk in Patients With High CVD Risk 
Physical Activity Reduces Stroke, Mortality, Regardless of A-Fib 
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
